Adams Diversified Equity Fund, Inc. Incyte Corp Transaction History

Adams Diversified Equity Fund, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$66.18 - $82.86 $9.03 Million - $11.3 Million	136,500 Added 81.35%	304,300 $20.3 Million
Q2 2022 Jul 27, 2022	BUY	$66.18 - $83.18 $11.1 Million - $14 Million	167,800 New	167,800 $12.7 Million
Q3 2020 Oct 20, 2020	SELL	$85.07 - $109.69 $6.29 Million - $8.11 Million	-73,900 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$74.18 - $108.93 $5.48 Million - $8.05 Million	73,900 New	73,900 $7.68 Million

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.